Surgical and Animal Core
Surgical and Animal Core
批准号:
7550195
负责人:
Dai Fukumura
金额:
$39.23万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal ModelAnimalsAntibioticsBlood VesselsBrainBreastBreedingCaringCephalicCharacteristicsDevelopmentDorsalEngineeringEnvironmentFatty acid glycerol estersFoundationsGenerationsGnotobioticGoalsImmunodeficient MouseImplantKnockout MiceLaboratoriesMaintenanceMammary glandModelingMolecularMonitorMusOperative Surgical ProceduresOrganParasitesPhysiologicalPlacementPumpQuality ControlRoleSkinSkin CancerTherapeutic AgentsTimeTissue SampleTransgenic OrganismsVirusanimal colonyanimal facilitycontrolled releaseimplantationin vivoinnovationmodel developmentnovelpathogenpathogenic bacteriasample collectiontherapy developmenttumor
中文摘要
我们实验室的一个标志是开发新颖和创新的体内肿瘤模型,
我们研究治疗药物输送的障碍。这是可能的,因为出色的外科手术
专业知识和独特的动物设施,在我们的实验室,这一核心作为其基础。这
核心将继续发挥两项功能:(i)手术支援,包括新的动物模型
发展;及(ii)饲养及饲养动物。两者都是成功完成所有
项目目标。因此,这一核心构成了我们PPG竞争性更新的基石。这一核心将
继续建立动物模型并提供给PPG的所有项目。透明窗口模型
- 乳房脂肪垫窗(所有三个项目)、颅骨窗(项目1、2)和背部皮肤
室(项目3)-能够在体内时间过程监测分子,细胞,解剖,
分别用于乳腺癌、脑癌和皮肤癌的原位器官环境中的功能参数。在
此外,自发性肿瘤使我们能够研究宿主微环境在肿瘤中的作用
发展和治疗。由这个核心维持的考克斯-7无菌动物群落使我们能够
在免疫缺陷小鼠中进行纵向生理学研究。这些研究极其困难
其他地方更贵。这个机构将继续为我们提供统一的实验动物
质量是免费的鼠病毒,致病菌和寄生虫。这使我们能够执行
不使用抗生素的外科手术。确定的植物群C3 H、FVB、C57 BL/6、裸菌、SCID、rag-T“
rag-T ′-,VTGFP-GFP/(FVB,C3 H,rag-Z ′-背景),Tie 2 p-GFP/(FVB,rag-T ′-背景),EF 1 cf-
GFP/FVB和ACTbp-GFP/C57 VL/6小鼠目前可在考克斯-7设施中获得。额外
所有项目的转基因和基因敲除小鼠也将被工程化或再衍生、繁殖和维持
在设施内的所有项目。将对筛选出的且不含小鼠病原体的肿瘤进行系列研究。
体内传代并植入殖民地内的实验动物。体内肿瘤不会
传代超过第五代(F5),以避免肿瘤特征的变化。这保证了紧
控制动物和肿瘤的质量。核心C也将继续提供控释泵
植入、组织样本收集、血管线放置和术后护理。
英文摘要
A hallmark of our laboratory is the development of novel and innovative in vivo tumor models that allow
us to study barriers to the delivery of therapeutic agents. This is possible due to the outstanding surgical
expertise and unique animal facility available in our lab, for which this Core serves as its foundation. This
Core will continue to serve two functions: (i) surgical support which includes novel animal model
development, and (ii) breeding and maintenance of animals. Both are vital for successful completion of all
project goals. Thus, this Core forms a cornerstone of the competing renewal of our PPG. This Core will
continue to establish and provide animal models to all Projects of this PPG. Transparent window models
- the mammary fat pad window (all three Projects), the cranial window (Projects 1, 2) and the dorsal skin
chamber (Project 3)- enable in vivo time-course monitoring of molecular, cellular, anatomical, and
functional parameters in orthotopic organ environments for breast, brain and skin cancers, respectively. In
addition, spontaneous tumors allow us to study the role of the host microenvironment in tumor
development and treatment. The Cox-7 gnotobiotic animal colony maintained by this Core allows us to
carry out longitudinal physiological studies in immunodeficient mice. These studies are extremely difficult
and more costly elsewhere. This facility will continue to provide us with experimental animals of uniform
quality that are free of murine viruses, pathogenic bacteria, and parasites. This enables us to carry out
surgical procedures without the use of antibiotics. Defined flora C3H, FVB,C57BL/6, Nude, SCID, rag-T''
rag-T'-, VTGFP-GFP/(FVB, C3H, rag-Z'' background), Tie2p-GFP/(FVB, rag-T'- background), EFlcf-
GFP/FVB, and ACTbp-GFP/C57VL/6 mice are currently available in the Cox-7 facility. Additional
transgenic and knock-out mice for all Projects will also be engineered or rederived, bred, and maintained
for all Projects within the facility. Tumors that are screened and free of mouse pathogens will be serially
passaged in vivo and implanted into experimental animals within the colony. In vivo tumors will not be
passaged beyond the fifth generation (F5) to avoid changes in tumor characteristics. This assures tight
control of the quality of animals and tumors. Core C will also continue to provide controlled-release pump
implantation, tissue sample collection, vascular line placement, and post-surgical care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
-
批准号:10582613
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2021
-
负责人:Dai Fukumura
-
依托单位:
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
-
批准号:10394968
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2021
-
负责人:Dai Fukumura
-
依托单位:
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
-
批准号:9403496
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2017
-
负责人:Dai Fukumura
-
依托单位:
Overcoming Resistance to Anti-VEGF Treatment of Colorectal Cancers
-
批准号:8463132
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2013
-
负责人:Dai Fukumura
-
依托单位:
Doppler Optical Frequency Domain Imaging Instrument
-
批准号:7793981
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2010
-
负责人:Dai Fukumura
-
依托单位:
Surgical and Animal Core
-
批准号:7118421
-
项目类别:
-
资助金额:$19.91万
-
财政年份:2006
-
负责人:Dai Fukumura
-
依托单位:
Vascular Normalization: Rolse of Perivascular Cells
-
批准号:7118413
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2006
-
负责人:Dai Fukumura
-
依托单位:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
-
批准号:7071781
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
-
批准号:7618192
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
-
批准号:6522149
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
-
批准号:7812092
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
-
批准号:6607130
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
-
批准号:8266301
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
-
批准号:8067766
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
-
批准号:6898399
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
NO in Tumor Angiogenesis,Microcirculation & Rad.Therapy
-
批准号:6748474
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
-
批准号:7372879
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2002
-
负责人:Dai Fukumura
-
依托单位:
Surgical and Animal Core
-
批准号:9057980
-
项目类别:
-
资助金额:$43.66万
-
财政年份:--
-
负责人:Dai Fukumura
-
依托单位:
Surgical and Animal Core
-
批准号:8299770
-
项目类别:
-
资助金额:$43.77万
-
财政年份:--
-
负责人:Dai Fukumura
-
依托单位:
Surgical and Animal Core
-
批准号:8463137
-
项目类别:
-
资助金额:$42.4万
-
财政年份:--
-
负责人:Dai Fukumura
-
依托单位:
海外基金